News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Daily News No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data Yael L. Maxwell February 15, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News Predictors of AF May Help Guide Care After Stroke of Unknown Cause Caitlin E. Cox October 26, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Daily News Trials Suggest Need for Prolonged AF Monitoring in More Stroke Patients Todd Neale June 04, 2021
News Daily News Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report Michael O'Riordan April 16, 2021
News Daily News Nonstenotic Intracranial Plaque: An Underrecognized Source of Embolic Stroke Todd Neale February 10, 2021
News Daily News FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion Todd Neale July 22, 2020
News Daily News HRS 2020 ‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib Todd Neale May 14, 2020
News Conference News CRT 2020 Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR L.A. McKeown February 24, 2020
News Conference News ESC 2019 Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy Todd Neale August 31, 2019
News Industry News Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation May 22, 2019
News Conference News EHRA 2019 Survey Says . . . Patients Like NOACs Better Than Warfarin Todd Neale March 17, 2019